Kaplan–Meier analysis showed that higher MACC1-AS1 or MACC1 expression was associated with reduced DFS (stage I–III GC patients) and OS (stage IV GC patients) compared to that in the corresponding low and negative expression groups (Fig. 1j–o). The gene discussed is MACC1; the disease is gastric cancer.